Results: 7
ASC nanobodies to counteract the consequences of inflammasome activation.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202216087
- By:
- Publication type:
- Article
Olverembatinib inhibits SARS‐CoV‐2‐Omicron variant‐mediated cytokine release in human peripheral blood mononuclear cells.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202215919
- By:
- Publication type:
- Article
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202215816
- By:
- Publication type:
- Article
Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202115415
- By:
- Publication type:
- Article
Liver gene therapy with intein‐mediated F8 trans‐splicing corrects mouse haemophilia A.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202115199
- By:
- Publication type:
- Article
Feed‐forward loops between metastatic cancer cells and their microenvironment—the stage of escalation.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202114283
- By:
- Publication type:
- Article
Caspase‐8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 6, p. 1, doi. 10.15252/emmm.202114121
- By:
- Publication type:
- Article